The Menarini Group Announced Marketing Authorization Applicati...
- Written by LATEST ASIANET NEWS RELEASES
- Category: Asia Net
FLORENCE, Italy, Mar. 10, 2018 /PRNewswire-AsiaNet/-- The Menarini Group announced today that on March 6th 2017 it submitted a Marketing Authorization Application for delafloxacin at the European Medicines Agency (EMA) under the trade name Quofenix. The proposed indication for delafloxacin in Eur......





